Fibrino Gens

Welcome on Recombinant Thrombin Activatable Fibrinolysis Inhibitor (TAFI) page

Recombinant Thrombin Activatable Fibrinolysis Inhibitor (TAFI)

General information

Catalog number
RPA615Mu03-500ug
Name
Recombinant Thrombin Activatable Fibrinolysis Inhibitor (TAFI)
Price
912.00 EUR
Size
500ug

Detailed information

Description
Recombinant Mouse Thrombin Activatable Fibrinolysis Inhibitor expressed in: E.coli
Specifications
Host species: Mus musculus (Mouse); Expression system: E.coli; Expression region: Pro187~Lys327; Purity: ≥ 92%; Endotoxin level:
Additional_information
Uniprot ID: Q9JHH6; Buffer composition: PBS, pH 7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.; Form: Freeze-dried powder; Predicted Molecular Mass (KD): 22.5kDa; Isoelectric Point: Inquire
Storage_and_shipping
Shipped on ice packs. Upon receipt keep at 2-8 °C for up to 1 month. For long term storage prepare working aliquots and keep frozen at -20 or -80 °C. Avoid repeated freezing and thawing.
Notes
Research Use Only.
Additional description
Tissue, pathway, proteinase, peptidase, protease ,acrosin, lipoprotein, activator, caspase, trypsin, papain, esterase inhibitors are proteins or receptor ligands or receptor antagonists that bind to an enzyme receptor and decreases its activity. Since blocking an enzyme's activity can kill a pathogen or correct a metabolic imbalance, many drugs are enzyme inhibitors. Not all receptor antagonist that bind to enzymes are inhibitors; enzyme activator ligands or agonists bind to enzymes and increase their enzymatic activity, while enzyme substrates bind and are converted to products in the normal catalytic cycle of the enzyme.
Source
Recombinants or rec. proteins
Group
recombinants